Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-24

Clinical Trial Update: COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for COSOPT (timolol/dorzolamide) in normal tension glaucoma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2011-03-24